Role of International Medical Graduates in the American College of Cardiology  by Dakik, Habib A.
*
E
P
D
B
*
H
2
K
E
R
1
2
3
4
5
R
A
C
f
a
c
c
fi
o
a
n
p
i
r
n
a
m
a
v
i
s
r
s
c
b
v
t
W
*
2
D
E
R
1
R
M
A
I
D
C
i
f
i
t
t
i
g
p
i
p
(
a
t
s
M
t
t
t
m
c
i
a
i
a
p
i
n
r
I
p
d
o
t
v
a
i
b
s
A
1039JACC Vol. 54, No. 11, 2009 Correspondence
September 8, 2009:1036–40Ernest C. Madu, MBBS
dwin Tulloch-Reid, MBBS
aul Edwards, MBBS
ainia S. Baugh, MD
. Waine Kong, PhD, JD
Cardiovascular Medicine and Imaging Technology
eart Institute of the Caribbean
3 Balmoral Avenue
ingston, Jamaica
-mail: emadu@caribbeanheart.com
doi:10.1016/j.jacc.2008.07.077
EFERENCES
. Weaver DW. President’s page: the continuing importance of interna-
tional engagement. J Am Coll Cardiol 2008;51:2193–4.
. Integrated Management of Cardiovascular Risk: report of a WHO
meeting, Geneva, Switzerland, July 9–12, 2002. Geneva: World Health
Organization, 2002.
. Madu EC, Richardson KD, Ozigbo OH, Baugh DS. Improving
cardiovascular disease prevention and management in Africa: issues to
consider for the 21st century. Ethn Dis 2003;13 Suppl 2:71–6.
. Heart Institute of the Caribbean. Available at: http://www.ted.com/
index.php/talks/view/id/249. Accessed June 7, 2008.
. Kong BW, Ntim W. Preventive cardiology in special patient popula-
tions—twelve days in Ghana. Cardiol Rev 2008;25:47–8.
eply
s an organization based in the U.S., the American College of
ardiology recognizes that it has as much to learn as it has to teach
rom our engagements with partners outside the U.S. The goals
nd examples outlined in the letter from Dr. Madu and colleagues
oncerning my recent report (1) are shared ones, and we must work
ollaboratively in order to reach them.
The College’s recent international strategy has been developed
rst and foremost to be collaborative and not prescriptive with
ther international societies and with our international members,
nd second, to work with willing partners to better understand the
eeds that cardiovascular specialists have on a local level to develop
rograms and products that help mitigate those challenges and
mprove the care of all patients with cardiovascular disease. For this
eason, the College has implemented a new international gover-
ance structure aimed at improving international representation
nd exchange. Our primary goals are to provide better value of
embership to our international members, to foster collaboration
round global issues, to improve the care of patients with cardio-
ascular disease, and last, to provide educational and quality
mprovement resources to those wishing to collaborate. We
trongly believe that our strategy of collaboration in both resource-
ich as well as resource-limited settings will help us to achieve our
hared vision of improving quality patient-centered cardiovascular
are globally. I urge you and other international members to
ecome involved in the International Council—which now pro-
ides forums for you to advance initiatives and sustainable struc-
ures to improve world cardiovascular health.
. Douglas Weaver, MD*
Henry Ford Heart and Vascular Institute
799 West Grand Boulevard K-14
etroit, Michigan 48202-2608
-mail: wweaver1@hfhs.orgdoi:10.1016/j.jacc.2009.05.042 rEFERENCE
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ole of International
edical Graduates in the
merican College of Cardiology
read with much interest the recent commentary by Dr. W.
ouglas Weaver (1), President of the American College of
ardiology (ACC), in which he addressed the challenges that
nternational medical graduates (IMGs) face when they enter
ellowship programs or clinical practice in the U.S. and proposed
deas to get them more involved and integrated in the functions of
he ACC. Because I am an IMG myself, it was rewarding to see
hat the ACC at its highest leadership level is genuinely interested
n the welfare of IMGs, who certainly go through difficult times to
et into a cardiology fellowship program in the U.S. in the first
lace.
Although most IMGs who complete their cardiovascular train-
ng end up staying in the U.S. in private practice or academic
ositions, a substantial portion do actually go to their countries
mainly developing countries) to start their careers there. Those
lso tend to disconnect from the ACC and, other than attending
he annual ACC or American Heart Association scientific ses-
ions, they are not so much involved in the functions of the college.
any of those IMGs have received rigorous research training in
he U.S. in addition to their clinical training, and unfortunately
heir research productivity significantly decreases once they leave
he U.S. (2). Limited funding, the absence of senior supporting
entors, and the lack of dedicated time all combine to significantly
urtail the research potential of IMGs returning to their develop-
ng countries. How can the ACC support and enhance the
cademic careers of IMGs in their home countries?
First, encourage them to continue their research and to publish
t. There is a feeling, which may be difficult to prove, that there is
certain bias in U.S. and European journals against research
erformed in developing countries. Most of the research conducted
n these countries is clinical rather than basic and although it might
ot be directly relevant to the U.S. health care system, it remains
elevant to “global cardiovascular health.” The ACC could help
MGs by having its journals more “open” to their research or
erhaps having a journal dedicated to cardiovascular health in
eveloping countries just like it has journals dedicated to imaging
r interventions.
Second, help them create a network with leading pharmaceu-
ical companies conducting clinical trials. Most of those companies
iew developing countries primarily as markets for their products,
nd although some of them are beginning to conduct clinical trials
n these countries, their attempts have not been always successful
ecause of the lack of supporting infrastructure and improper
election of sites and investigators. Proper networking among the
CC, pharmaceutical companies, and investigators with solidesearch background can ensure the success of the clinical trials
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September 8, 2009:1036–40onducted and at the same time enhance the academic careers of
he investigators involved.
A third way the ACC could support IMGs and at the same time
chieve its mission to improve global cardiovascular health is by
onducting some of its educational programs and workshops in
eveloping countries and getting IMGs in these countries inti-
ately involved in these programs.
The interest of the ACC leadership in IMGs is an important
ositive step forward. The IMGs remaining in the U.S. and those
eturning to their home countries possess tremendous clinical and
esearch potentials that should be used effectively to improve the
lobal cardiovascular health and fulfill the mission of the ACC.
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eply
thank Dr. Dakik for taking the time to respond to my
ommentary on international medical graduates (1). His thought-
ul response reinforces the need to encourage opportunities for
rainees who do return to their home countries to help address the
ardiovascular health care of their country folk.
I will be sure to forward Dr. Dakik’s thoughts to our new
nternational Council for their consideration as they begin to chart
1course and set of activities. The Council’s first meeting was at our
nnual Scientific Sessions in Orlando, Florida, this past March. It
s primarily composed of members of the American College of
ardiology from outside of the U.S., many of whom will likely
ave had the same experiences and impressions as Dr. Dakik. The
ouncil is one outcome of several years of planning to better meet
he needs of cardiovascular medicine in other countries of the
orld.
Another result of the international strategy is the provision for
merican College of Cardiology country chapters in collaboration
ith existing national chapters—an approach that is ideally suited
o support Dr. Dakik’s ideas. Leading College members in these
ountry chapters can encourage cardiologists to pursue their
cholarship, advise them on preparing their papers, and direct their
ubmission to the most promising journals. This strengthened
etwork provides the means through which pharmaceutical inter-
sts can identify and support researchers and clinical trial needs.
nd, one can be reassured that one key goal of the International
ouncil and country chapters will be to enhance educational
rograms and workshops in country.
I welcome readers’ continued support of the College and regular
isits to our online source of international news and perspectives at
he ACC International Center: www.acc.org/about/international/
nternationl.htm.
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